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Prologue: Biliary System - History 
and Background
Sam Koruth and Sooraj Sankar
1. Introduction
Cholecystectomy is one of the most common surgeries performed all around the 
world; over 600,000 people in the US undergo cholecystectomies each year. It is the 
treatment of choice for inflammation of the gallbladder (cholecystitis), pain and 
inflammation related to gall stones (calculus cholecystitis) and pancreatitis caused 
by gall stones.
Carl Johann August Langenbuch, a 27-year-old director of the Lazarus Hospital 
in Berlin, first practiced cholecystectomy on a cadaver, and then in the year 1882, 
he performed a cholecystectomy on a man who had suffered from gallstones for 
16 years and cured his painful condition overnight. He was initially frustrated and 
disturbed that his patients continued to suffer after minor procedures to drain or 
clean the gallbladder, and then he became determined to give these patients a cure 
rather than temporary relief, and thus the first open cholecystectomy captured the 
history books.
By 1897, over 100 cholecystectomies had been performed, and it turned out that 
the removal of the gallbladder not only would not take life but could in fact provide 
a pain-free future. Then in 1985, the modern era of cholecystectomies began when 
the surgeon Erich Mühe of Böblingen, Germany, did the first endoscopic cholecys-
tectomy. Thereafter the pioneers in France and the US surgeons attached a CCD 
video camera to a laparoscope allowing the surgical team to view the operative field 
and perform with laparoscopic instruments. A French gynecologic surgeon per-
formed a laparoscopic gallbladder removal in 1987. Soon after that in just 2 years, 
demand for the laparoscopic approach transformed surgical practice in the US and 
other countries and subsequently recognized laparoscopic cholecystectomies as 
the gold standard treatment for gallstone disease. The benefits of the laparoscopic 
approach were ultimately codified in the new National Institutes of Health (NIH) 
guidelines in 1992, and they stated that it provided a safe and effective treatment for 
most patients with symptomatic gallstones.
To date, it is documented that more than 80% of the cholecystectomies are done 
via laparoscopic approach. The advantages of laparoscopic over open surgeries are 
quite clear. These advantages include shorter length of hospital stay, very less opera-
tive pain, avoiding a big scar over the abdomen, earlier return of bowel function, 
improved cosmesis, earlier return to normal activities and overall decreased cost. 
The rates of cholecystectomies have increased subsequently with the introduction 
of laparoscopic procedures accompanied by evidence of lower clinical thresholds for 
operative therapy of gallstone diseases.
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2. Tips for a safe cholecystectomy
I have personally penned down certain points in my personal experience which 
can be used as a guide or may be even as a checklist before the young talented 
surgeons place their hands on cholecystectomies:
1. Selection of initial cases—female thin built patients with short history of 
biliary colics and especially no history of cholecystitis as there would be adhe-
sions and would be a task to dissect during the initial days.
2. Informed consent including chances of conversion and high risk of various 
injuries to bile duct or other nearby structures.
3. Proper cleaning and sterilization of instruments.
4. Good quality equipment and instruments.
5. A good first assistant and a qualified and trained surgeon.
6. Formal training in laparoscopic surgeries to have a basic knowledge about the 
instruments and the technique.
7. 30° telescope.
8. Open technique of first port.
9. Urine to be evacuated just before the surgery.
10. Fundus should be retracted towards the right shoulder.
11. Vascular anatomy and biliary tract anatomies are different and vary from 
person to person.
12. Consider cystic lymph node of Lund as a guide for the cystic duct.
13. Hydrodissection and suction cannula can be a good instrument for blunt 
dissection.
14. It is safer to leave a few mm of cystic duct than to shave it off near to the com-
mon bile duct.
15. Double clips are always safer on the patient side of the structures.
16. Cystic ducts can be wider, longer, tortuous, double or even very short.
17. Fundus-first techniques can be adopted for difficult cases.
18. Bleeding seen on the screen will usually be less as they are magnified versions.
19. All bleedings will stop with pressure except the physiological menstrual bleed. 
So in case if there is bleeding, avoid panic, give pressure with gauze piece and 
control the bleed.
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20. Partial cholecystectomies are an option for difficult cases.
21. Do not hesitate to open the abdomen in case of bleeding or difficult anatomy.
22. All stumps should be carefully examined.
23. Bile spillage and stone spillage should be sucked out or removed.
24. Conversions are not failures, and surgeons should not have an ego to finish all 
cases via a laparoscopic approach.
25. Whatever taken out of the body including all gallbladders should be sent for 
histopathology.
3. Gallstone pancreatitis
Acute pancreatitis is now the most common reason for hospital admission 
among all gastrointestinal disorders [1]. Population-based studies indicate that the 
incidence of acute pancreatitis is rising from 14.8 in 100,000 (1990–1994) to 31.2 in 
100,000 (2010–2013) among British males [2]. The most common (about 30–50%) 
preventable cause of pancreatitis in the United Kingdom is gallstones [3]. Recurrent 
attacks of gallstone pancreatitis (GSP) carry a mortality rate of 10% and a major 
morbidity rate of 30–40%. Most of these cases follow a mild course and are self-
limited with supportive care, but approximately 20% progress to severe disease, 
requiring a prolonged hospital stay and intensive care, and are associated with a 
mortality rate approaching 30%. Three key areas in the management of patients 
with gallstone pancreatitis are diagnosis, risk stratification with predictors of 
severity and the type and timing of definitive intervention. In this chapter we have 
attempted to cover all relevant clinical aspects of gallstone pancreatitis regarding its 
etiopathogenesis, disease severity and management.
3.1 Etiopathogenesis
Considering all non-malignant gastrointestinal diseases, currently acute pancre-
atitis has become the most frequent reason for hospital admission. An overall mortal-
ity of 4.3% within 90 days and a 1-year mortality of 7.9% make it a lethal disease [2]. 
Gallstone disease is becoming more common along with heavy alcoholism as the 
cause of pancreatitis. Population-based studies indicate that the prevalence of gall-
stones in some Western countries surpasses 20% of the adult population [4].The con-
tinuous rise in gallstone prevalence is much more likely to be due to nutritional and 
life style factors, though genetic predisposition plays an important part in formation 
of gallstones [5, 6]. When a patient develops pancreatitis due to gallstones, the disease 
is likely to recur until the migrating bile duct stones are removed or their impaction at 
the duodenal papilla is prevented. According to a study involving some 5000 patients 
admitted with first episode of acute gallstone-associated pancreatitis, the recurrence 
rate was reduced from 30 to 6.7% with endoscopic sphincterotomy done during the 
first week; an elective interval cholecystectomy reduced it to 4.4%, and it was further 
reduced to 1.2% by performing endoscopic sphincterotomy combined with elective 
cholecystectomy during the same hospital admission [7]. The manipulation of the 
papilla while removing a gallstone or during a sphincterotomy, the consequent swell-
ing can obstruct the pancreatic duct, and triggers pancreatitis in some patients. A way 
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to address this problem is the transient insertion of small plastic stent into the pancre-
atic duct, which prevents the prolonged impairment of pancreatic secretion and has 
been shown to significantly reduce the incidence of ERCP-induced pancreatitis [8].
Taking into account the observations from various clinical and population-based 
studies:
a. Carrying gallstones increases the risk of developing acute pancreatitis.
b. Only gallstones that are small enough to pass through the biliary tract confer 
a pancreatitis risk, rather than the ones that remain asymptomatically in the 
gallbladder.
c. The risk of developing pancreatitis in the first place and the risk of a recurrence 
of pancreatitis can be reduced by strategies intended to remove the source of 
migrating gallstone or that prevent their impaction near the duodenal papilla.
d. Preserving the flow from the pancreatic duct is an effective way of preventing 
ERCP-induced pancreatitis.
3.2 Mechanisms of gallstone-induced pancreatitis
In 1856, Claude Bernard discovered that bile, when injected into the pancreatic 
duct of laboratory animals, can cause pancreatitis [9]. It is firmly established today 
that requires the passage of a gallstone from the gallbladder through the biliary tract 
causes initiation of pancreatitis and not gallstones, which remain in the gallbladder 
[10]. Eugene Opie, in 1901, postulated that impairment of the pancreatic outflow 
due to obstruction of the pancreatic duct causes pancreatitis [11]. Later, he modi-
fied this theory and published “common channel hypothesis,” which predicted that 
an impacted gallstone at the papilla of Vater creates a communication between the 
pancreatic and the bile duct (the so-called common channel) through which bile 
flows into the pancreatic duct and thus causes pancreatitis (Figure 1).
There is inadequate experimental and clinical evidence compatible with Opie’s 
assumptions. In fact, anatomical studies have shown that an impacted gallstone 
would most likely obstruct both common bile duct and pancreatic duct [12], as the 
communication between the pancreatic duct and the common bile duct is much too 
short (< 6 mm) to permit biliary reflux into the pancreatic duct [13]. The pancre-
atic secretory pressure is higher than biliary pressure, and pancreatic juice would 
flow into the bile duct rather than bile into the pancreatic duct, in the event of an 
existing anatomical communication between bile and pancreatic ducts [14, 15]. 
However, when pancreatic necrosis is firmly established, the observation of a bile-
stained necrotic pancreas at the time of surgery may explain a biliopancreatic reflux 
due to a loss of barrier function in the damaged pancreatic duct. But this should not 
be regarded that biliary reflux initiates the disease process.
The “common channel” hypothesis has its own inconsistencies. In order to over-
come that, it was proposed that the passage of a gallstone could damage the duodenal 
sphincter in a manner to cause sphincter insufficiency. This, in turn, could permit 
duodenal content, including bile and activated pancreatic juice, to flow through the 
incompetent sphincter and into the pancreatic duct [16], thus inducing pancreatitis. 
The perfusion of bile through the pancreatic duct has been shown to be completely 
harmless [17]. It has been identified that an influx of infected bile, which might occur 
after prolonged obstruction at the papilla, may represent an aggravating factor, as 
opposed to an initiating event, for the course of pancreatitis when the pressure gradi-
ent between the pancreatic duct (higher) and the bile duct (lower) is reversed [18, 19].
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These data rtaken together, it is the acinar cells which are affected by the initial 
pathophysiological events [20] and are triggered by obstruction or impairment 
of flow from pancreatic duct, in accordance with Opie’s initial hypothesis. Biliary 
reflux into pancreatic duct, by whichever mechanism, is neither required nor likely 
to occur during initial course of acute pancreatitis [21].
Intra-acinar pancreatic enzyme activation induces auto digestion of normal 
pancreatic parenchyma. As a result, acinar cells release proinflammatory cytokines, 
such as tumor necrosis factor-α (TNF-α) and interleukin (IL)-1, IL-2 and IL-6, and 
anti-inflammatory mediators, such as IL-10 and IL-1 receptor antagonist. These 
mediators propagate the initial injury response locally and systemically so that 
TNF-α, IL-1 and IL-7, neutrophils and macrophages are recruited into the pan-
creatic parenchyma and cause the release of more TNF- α, IL-1 and IL-6, reactive 
oxygen metabolites, prostaglandins, platelet-activating factor and leukotriene. The 
local inflammatory response increases the permeability and causes damages to the 
microcirculation of the pancreas further aggravating the pancreatitis. Local hemor-
rhage and pancreatic necrosis occur in severe cases as a result of local inflammatory 
response. In addition, neutrophils release some of the inflammatory mediators and 
aggravate the pancreatic injury by causing pancreatic enzyme activation [22].
The inflammatory cascade is self-limited in approximately 80–90% of patients. 
However, in the remaining patients, a vicious circle of recurring pancreatic injury 
and local and systemic inflammatory reaction persist. In a small number of patients, 
there is a massive release of inflammatory mediators to the systemic circulation. 
Figure 1. 
The two “Opie hypotheses” for the pathogenesis of gallstone induced pancreatitis. (A) A gallstone in the biliary 
tract obstructs the pancreatic duct to cause an impaired flow from the exocrine pancreas triggering acinar 
cell or duct cell damage. Obstruction of the common bile duct is immaterial to the triggering mechanism of 
pancreatitis in this scenario. (B) The duodenal papilla is obstructed by an impacted gallstone, and creates a 
communication between the pancreatic duct and the common bile duct. This “common channel” allows passage 
of bile into the pancreatic duct and would trigger the onset of acute pancreatitis. Lerchand Aghdassi [23].
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Active neutrophils mediate acute lung injury and induce the adult respiratory distress 
syndrome frequently seen in patients with severe pancreatitis. The mortality seen in 
the early phase of pancreatitis is the result of this persistent inflammatory response.
3.3 Clinical presentation
The patients with gallstone pancreatitis usually present with acute onset of epi-
gastric pain that radiates to back. The pain is unrelenting and accompanied typically 
by severe nausea and occasional vomiting. In the presence of choledocholithiasis/
acute cholangitis, they have high-grade fever with chills, jaundice, acholic stools and 
dark urine as accompaniments.
3.4 Disease severity
In general, patients with gallstone pancreatitis can be classified into one of the 
three categories (mild acute pancreatitis, moderately severe acute pancreatitis and 
severe acute pancreatitis) according to pancreatic morphology, the presence of organ 
failure and local or systemic complications (Table 1). Morphologically as assessed by 
CECT, acute pancreatitis is defined as interstitial pancreatitis, which is characterized 
by edematous changes in the pancreatic parenchyma with or without accompanying 
acute peripancreatic fluid collections (APFC; Figure 2) or necrotizing pancreatitis 
with the presence of nonviable pancreatic parenchyma and, most typically, a sur-
rounding acute necrotic collection (ANC; Figure 3) in the peripancreatic tissues. 
Organ failure in patients with gallstone pancreatitis may be transient (less than 48 h) 
or persistent (more than 48 h) and usually initially is accompanied by respiratory 
failure followed by renal failure and, in severe cases, cardiovascular failure. The 
Modified Marshall scoring system is being used to grade organ dysfunction by the 
2012 revised Atlanta classification of acute pancreatitis, but for categorizing and 
managing patients with gallstone pancreatitis, the presence of transient or persistent 
single- or multi-organ failure is adequate. Local complications of pancreatitis are 
defined as an APFC, acute necrotic collection (ANC), pancreatic pseudocyst (PP) or 
walled-off pancreatic necrosis (WOPN). Briefly, peripancreatic fluid in the presence 
of interstitial edematous pancreatitis without necrosis is called an APFC, and it often 
Mild acute pancreatitis Moderately severe 
pancreatitis
Severe acute 
pancreatitis
Morphology Interstitial/edematous Necrotizing Necrotizing
SIRS response Absent Transient Persistent for 
1–2 weeks
Organ failure Absent <48 h >48 h
Local complications
APFC Occasional Often Present initially
ANC Absent Occasional Present
PP Absent Rare Occasionally
WOPN Absent Rare Often
Risk of infection Nil Low Moderate
ANC, acute necrotic collection; APFC, acute peripancreatic fluid collection; PP, pancreatic pseudocyst; SIRS, systemic 
inflammatory response syndrome; WOPN, walled-off pancreatic necrosis.
Table 1. 
Characteristics of the various forms of gallstone pancreatitis (2012 revised Atlanta classification).
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resolves spontaneously within weeks. An ANC is a collection of fluid and necrosis 
associated with necrotizing pancreatitis, and it may involve the parenchyma, the 
peripancreatic tissues alone or both the pancreas and the retroperitoneal tissues. A 
pancreatic pseudocyst is an encapsulated, homogenous, enzyme-rich fluid collec-
tion with a well-defined wall that matures over 4 weeks. Finally, WOPN is a mature 
encapsulated collection of necrosis that develops over 4 weeks. Systemic complica-
tions of pancreatitis represent exacerbations of pre-existing comorbidities, such as 
coronary artery disease or chronic obstructive pulmonary disease.
3.4.1 Mild acute gallstone pancreatitis
Abdominal pain, nausea or vomiting; an increased serum amylase or lipase 
concentration; and transient increases in serum bilirubin, alkaline phosphatase 
or alanine aminotransferase concentrations characterize patients with mild acute 
gallstone disease. These symptoms and abnormal laboratory findings usually abate 
within 24–48 h. CECT is not indicated, because an APFC is not present or is not 
significant clinically. These findings are consistent with a gallstone or sludge which 
produced a transient obstruction of the pancreatic duct. The presence of gallstones 
is confirmed by an abdominal ultrasonography.
3.4.2 Moderately severe gallstone pancreatitis
A patient with moderately severe gallstone pancreatitis is complicated by 
persistent typical abdominal symptoms that may be accompanied by the presence 
Figure 2. 
APFC.
Figure 3. 
WOPN.
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of a fever, leukocytosis or persistently increased pancreatic- and/or liver-associated 
enzymes. These symptoms persist for over 48 h and may be accompanied by 
transient organ failure manifested by increasing oxygen requirements and an 
abnormally elevated creatinine or blood urine nitrogen (BUN). A CECT is indicated 
provided the symptoms last for more than 3 days, and that may reveal interstitial, 
edematous pancreatitis with an APFC or sterile pancreatic necrosis without per-
sistent organ failure. Magnetic resonance cholangiopancreatography (MRCP) is 
indicated to confirm or exclude the presence of an obstructing stone in patients 
with continually increased liver-associated enzymes (bilirubin >4) which may have 
biliary obstruction from gallstones.
3.4.3 Severe acute gallstone pancreatitis
Patients with severe acute gallstone pancreatitis have severe abdominal symp-
toms and develop persistent single or multiple organ failure. These patients exhibit 
signs of the systemic inflammatory response syndrome with tachycardia, hypo-
thermia or hyperthermia, leukocytosis and tachypnea. They require admission to 
the intensive care unit and often require intubation and mechanical ventilation, 
renal replacement therapy and/or inotropic support due to progressive organ 
failure. After resuscitation and stabilization, CECT may demonstrate pancreatic 
necrosis with local complications; however, necrotizing pancreatitis evolves over 
days and weeks, and early CECT may not demonstrate significant pancreatic or 
peripancreatic findings. Patients with high suspicion of acute cholangitis require 
evaluation with MRCP, and perhaps, in these critically ill patients, the most 
efficient procedure for the relief of biliary obstruction is endoscopic retrograde 
cholangiopancreatography (ERCP).
3.5 Diagnosis
A definitive diagnosis of acute pancreatitis requires two of the following three 
criteria:
(1) Abdominal pain that is constant, severe, epigastric and often radiating 
to the back; accompanied by nausea, vomiting and anorexia; and exacerbated 
by oral intake; (2) serum lipase (or amylase) level at least three times the upper 
limit of normal; and (3) characteristic imaging findings, ideally with a contrast-
enhanced computed tomography (CT). It is often advisable to delay CT for 72 h, 
in patients with typical abdominal pain and elevated lipase or amylase, and at 
that time to perform a dedicated pancreas protocol CT (PPCT) with an early 
arterial phase and a delayed portal venous phase, ideally calibrated to cardiac 
output. Important advantages of this 72-hour delay in the PPCT include avoiding 
excessive radiation and contrast exposure associated with repeat CT imaging, 
allowing free fluid to begin to coalesce and increasing the ability to distinguish 
pancreatic necrosis from transiently ischemic areas. In some cases of obviously 
mild pancreatitis, or frequently recurrent alcoholic pancreatitis, CT may be 
omitted.
The diagnosis of gallstones as the cause of the pancreatitis is largely a diagnosis 
of exclusion. Careful history-taking is essential for patients who have acute pancre-
atitis to help rule out non gallstone causes. In addition, several different laboratory 
values, such as elevated aminotransferases, bilirubin and alkaline phosphatase, are 
useful in identifying a biliary origin of pancreatitis. Initial imaging with ultrasound 
(US) is essential to confirm the presence of gallstones or sludge and to measure the 
diameter of the common bile duct. Although the US is optimally 95% sensitive in 
detecting cholelithiasis, in gallstone pancreatitis, the sensitivity may decrease to 
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60% from 80% because of the increased bowel gas caused by concomitant ileus. A 
CECT with pancreatic protocol is indicated in patients with moderate and severe 
pancreatitis, ideally 48–72 h after diagnosis, and may demonstrate pancreatic 
necrosis with local complications (Table 2).
3.6 Treatment
In acute gallstone pancreatitis, intravenous fluid resuscitation is the mainstay of 
treatment regardless of disease severity. All patients require frequent serial re-
evaluations because even patients with apparently mild disease may go on to rapidly 
develop severe pancreatitis and require intensive care, which may include mechani-
cal ventilation and cardiovascular support.
3.6.1 Mild-moderate disease
The initial fluid administration should be in boluses followed by titration 
of infusion based on urine output, heart rate, blood pressure and correction of 
acidemia. Oral intake may be restricted in these patients on presentation but 
should begin soon after, as tolerated, typically within 24 h. If nausea and vomiting 
persist, however, nasogastric tube decompression can protect against vomiting and 
aspiration. While this treatment is going on, the primary complaint of the patient 
is to be addressed, which is severe abdominal pain. This is taken care of mainly by 
intravenous opiates. There is no role for prophylactic antibiotics unless an infec-
tion has been identified. However those patients with cholangitis and those who 
go on to develop extensive necrotizing pancreatitis, intravenous antibiotics may be 
warranted. Patients with significant cholangitis in addition to gallstone pancreatitis 
require urgent ERCP. Some people advocate early routine ERCP for all patients, but 
the latest guidelines limit ERCP and sphincterotomy to those patients with severe 
disease, to decrease complications.
Patients with moderately severe gallstone pancreatitis have evidence of local 
complications from pancreatic injury and transient organ failure and thus should be 
managed in a monitored setting. Because organ failure is transient with this condi-
tion, rapid improvement is anticipated, and a prolonged intensive care unit stay 
should be unnecessary.
Finding Points
Grade A: Normal pancreas 1
B: Pancreatic enlargement 2
C: Pancreatic or peripancreatic inflammation 3
D: Single peripancreatic fluid collection 4
E: Two or more fluid collections or peripancreatic air 5
Necrosis <30% 2
30–50% 4
>50% 6
CT severity index 0–3 (%) 4–6 (%) 7–10 (%)
Morbidity 8 35 92
Morality 3 6 17
Table 2. 
Computer tomography severity index (Balthazar score).
Digestive System - Recent Advances
10
However, the duration of hospitalization may be dependent on the local compli-
cations related to pancreatic injury. Edematous pancreatitis with an APFC should 
resolve relatively quickly, whereas sterile necrosis may cause persistent symptoms 
and limit per oral intake, necessitating institution of enteral nutrition. For patients 
who have sterile necrosis, follow-up CECT is recommended to ensure resolution of 
the pancreatic injury without complicating features such as the development of a 
pancreatic pseudocyst.
Laparoscopic cholecystectomy should be offered to patients with mild GSP 
during the index hospitalization, generally as soon as the patient is stable with 
significant resolution of acute symptoms.
3.6.2 Severe disease
Patient with severe disease should be treated aggressively in a higher center with 
well-equipped intensive care units, endoscopy and operative rooms all of which are 
staffed by critical care experts, gastroenterologists, interventional radiologists and 
surgeons. These patients develop a profound SIRS response and often have rapid 
deterioration requiring intubation and mechanical ventilation, renal replacement 
therapy and inotropic support. This critical period is driven by cytokine response 
and may last for 1–2 weeks. Aggressive fluid resuscitation is the cornerstone of 
initial therapy in severe. The goals of therapy during this period of critical illness 
include maintenance of oxygen delivery to the central nervous system and viscera 
by mechanical ventilation, adequate resuscitation with Lactated Ringer’s solution, 
inotropic administration as needed to support blood pressure and decrease heart 
rate, maintenance of renal function with or without renal replacement therapy and 
nutritional support. Enteral nutrition should be tried, though less often possible, 
because of less incidence of infected pancreatic necrosis. Antibiotics are often used 
to prevent conversion of sterile necrosis to infected necrosis, if the necrosis is <30%.
As the systemic inflammatory response wanes over 1–2 weeks, these patients 
will develop local complications of necrotizing pancreatitis. An early ERCP plus 
sphincterotomy along with conservative management can help decrease complica-
tions of severe disease. By 4–6 weeks these complications mature and management 
to be guided according to symptoms. Unlike in mild disease, an early operation 
should be avoided in severe pancreatitis, whether for cholecystectomy or pancreatic 
debridement. There are, however, a few notable exceptions, such as abdominal 
compartment syndrome, refractory hemorrhage and colonic necrosis or perfora-
tion, in which case immediate operation is warranted.
An ANC accompanying pancreatic necrosis may be sterile or infected. Sterile 
necrosis often requires no intervention, and patients recover over time except for 
the infrequent patient who develops failure-to-thrive syndrome as a result of sterile 
necrosis. Patients with failure-to-thrive syndrome may require percutaneous drain-
age or endoscopic or operative debridement for full recovery. Those patients with 
infected necrosis require drainage and debridement of infected pancreatic tissues 
with vigorous antibiotic therapy. The mode of drainage or debridement can vary 
from percutaneous drainage, endoscopic or laparoscopic debridement to dual-
modality drainage (combined percutaneous and endoscopic drainage). The open 
surgical approaches are heterogenous, and some of these approaches are no longer 
used in contemporary management.
Importantly, before debridement, a CECT should be obtained to ascertain 
the presence of the disconnected pancreatic duct syndrome. A viable pancreatic 
remnant in the tail separated by a substantial area of pancreatic necrosis in the neck 
of the gland should lead to the suspicion of a disconnected pancreas. This warrants 
the need for distal pancreatectomy and splenectomy accompanied by pancreatic 
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debridement as necessary, regardless of the surgical approach. Finally, concomitant 
with or following pancreatic drainage or debridement, the patient must have a 
cholecystectomy to prevent further episodes of gallstone-induced pancreatitis. The 
outcomes of patients with severe acute gallstone pancreatitis are variable depending 
on the patient’s overall condition, the extent of the disease, the type of procedure 
performed, the expertise of the providers and the institutional experience with 
such patients.
4. Conclusion
Acute gallstone pancreatitis represents a wide spectrum of disease ranging from 
mild disease that resolves spontaneously to severe disease with SIRS and necrotiz-
ing pancreatitis. These patients are best managed by a multidisciplinary approach 
to combat complications. Finally they should have a timely cholecystectomy to treat 
the cause of disease.
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